Home » Topics » BioWorld Science

BioWorld Science
RSS

New formulation of CGP-41251

July 26, 1996

Tyrosine kinase inhibitors in Pharmacia & Upjohn's pipeline

July 26, 1996

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Larifane shown effective in cervical dysplasia/cancer patients

July 26, 1996

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...